HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

2-Propyl-4,7-dihydro-1,3-dioxepine

HCID 260925
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
4469-34-5
Standard SMILES
CCCC1OCC=CCO1
InChIKey
RUTBWJOYERVBCR-UHFFFAOYSA-N
Molecular formula
C8H14O2
Average molar mass
142.2 g/mol
Monoisotopic mass
142.09937969

Names & identifiers

Preferred name
2-Propyl-4,7-dihydro-1,3-dioxepine
IUPAC
2-propyl-4,7-dihydro-1,3-dioxepine
English name
n-Propyl Dioxepin
Molecular formula
C8H14O2
Molecular weight
142.2

Names & synonyms

2-propyl-4,7-dihydro-1,3-dioxepine4469-34-5DTXSID60293875RefChem:1064588DTXCID00245015VITAMIN B6 IMPURITY 11,3-Dioxepin,4,7-dihydro-2-propyl-2-PROPYL-4,7-DIHYDRO-1,3-DIOXEPINN-propyldioxaneN-propyl heptylNSC92757VITAMINB6IMPURITY1
Show more names
4,4'-(oxybis(methylene))bis(5-(hydroxymethyl)-2-methylpyridin-3-ol)n-propyl heptahedralPyridoxine Impurity 42-Propyl-4,7-dihydro-1,3-dioxoheptane
N-propyl dioxy-heptacyclicSCHEMBL27762788EX-A3279MFCD19441326NSC-927571,3-Dioxepin, 4,7-dihydro-2-propyl-AS-938202-propyl-4,7-dihydro-2H-1,3-dioxepine

Database identifiers

CAS
4469-34-5
PubChem CID
260925
DTXSID
DTXSID60293875

Properties

Computed structural propertiesFilling in

XLogP
1.6
Topological polar surface area
18.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
10
Formal charge
0
Complexity
99.8

Physicochemical properties

Boiling point
70 · 70-72 °C(Press: 16 Torr)
Density
0.925 · 0.925±0.06 g/cm3(Predicted)
InChI
InChI=1S/C8H14O2/c1-2-5-8-9-6-3-4-7-10-8/h3-4,8H,2,5-7H2,1H3
InChIKey
RUTBWJOYERVBCR-UHFFFAOYSA-N
SMILES
O1CC=CCOC1CCC

Chemistry & industry

Applications

Usesn-Propyl Dioxepin has been shown to be a wonderfully proficient antagonist of the dopamine receptors, its ability to be leveraged in the creation of new pharmaceuticals that are aimed at treating a range of neurological disorders.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes